Cell-free Protein Synthesis Enables Rapid Single-chain Fragment Production and Analysis
Posted on Thursday, July 9, 2026
By
Topic: Tips for the lab
Single-chain antibody fragments, like VHH and scFv, are increasingly popular in therapeutics due to their smaller size, increased permeability, and enhanced solubility and thermal stability when compared to traditional antibodies. Cell-free protein synthesis (CFPS) workflows offer fast, scalable and cost-effective production. CFPS is also straightforward to optimize for challenging construct expression and can be seamlessly integrated with high-throughput DNA assembly.
In a recent application note, New England Biolabs scientists highlight a rapid, efficient screening method for novel antigen-binding fragment discovery and initial characterization.
Reproducibly going from DNA to data in hours instead of days
With rapid DNA assembly and amplification options, researchers can go from single-chain antigen-binding fragments to purification or direct analysis through biolayer interferometry (BLI) in one day. NEB scientists used VHHs and scFvs in the experiments outlined in the application note, but the methodology can be applied to other antibody fragments or miniprotein binders.
While CFPS templates need a T7 promoter, templates can be purified plasmids or a variety of amplified products. This compatibility with amplification products, including rolling circle amplification and polymerase chain reaction products, provides workflow adaptability for a variety of upstream strategies.
Cell-free expression can be coupled with affinity purification using Ni-NTA magnetic beads for a streamlined, rapid and automation-friendly approach to creating analytical amounts of diverse target proteins. This can take protein generation from a days-long process to an hours-long one.
NEB scientists have found that the NEBExpress® Cell-free E. coli Protein Synthesis System reproducibly produces soluble VHHs and with sufficient yield for downstream BLI analysis. The DNA-to-analysis workflow can be further streamlined through BLI analysis of antibody fragments directly from CFPS without purification.
Cell-free protein synthesis as a powerful platform for antibody research
CFPS is open and modular, which allows for rapid and systematic parameter exploration without the constraints of cellular viability. Primary determinants of functional yield for antibody fragments are folding efficiency and disulfide bond formation, so the flexibility of CFPS enables researchers to explore expression improvements and quickly identify optimal conditions for solubility, folding, and analysis.
Learn more about how to accelerate your antibody research using cell-free protein synthesis
For the specific methodology our scientists used, including volumes and tips for BLI and Surface Plasmon Resonance (SPR) data acquisition, check out our full application note.
Read the Full Application Note
NEB will not rent, sell, or otherwise transfer your data to a third party for monetary consideration. See our Privacy Policy for details. View our Community Guidelines.
Products and content are covered by one or more patents, trademarks and/or copyrights owned or controlled by New England Biolabs, Inc (NEB). The use of trademark symbols does not necessarily indicate that the name is trademarked in the country where it is being read; it indicates where the content was originally developed. All other trademarks are the property of their respective owners. The use of this product may require the buyer to obtain additional third-party intellectual property rights for certain applications. For more information, please email busdev@neb.com.
Don’t miss out on our latest NEBinspired blog releases!
- Sign up to receive our e-newsletter
- Download your favorite feed reader and subscribe to our RSS feed
Be a part of NEBinspired! Submit your idea to have it featured in our blog.
